Effectiveness of multi-stage diabetes screening in the dental care setting: a scoping literature review Authors: M. K. Sandhu, I. L. C. Chapple, R. Al-Falaki, N. Barker, Z. Yonel Published: 2026 ABSTRACT BackgroundDiabetes is of great interest globally, given the associated health and economic costs. It may impact long-term systemic and oral health with unfavourable outcomes when undetected or poorly controlled, leading to various oral manifestations, including premature tooth loss and reduced quality of life. Early detection can enable early diagnosis, intervention and improve treatment and health outcomes.AimsTo synthesise evidence on risk‑targeted screening and early case‑detection protocols for Type 2 Diabetes (T2D) that incorporate HbA1c or glucose point-of-care testing (POCT) using finger‑stick (FSB) or gingival crevicular blood (GCB) with a clinical risk assessment, to ascertain the value and potential impact of chair-side testing if implemented in primary care dental settings.MethodsElectronic databases were searched using a pre-defined strategy, identifying 21 eligible studies; nine studies focused primarily on identifying at-risk individuals through finger-stick testing and twelve through gingival crevicular blood testing. Returned articles and grey literature were screened and used as supportive material for later discussion. A descriptive synthesis of 21 articles was undertaken, with focus of the review on multi-stage chair-side diabetes screening protocols incorporating risk questionnaires and periodontal examinations and HbA1c or glucose POCT testing.ResultsChair-side HbA1c-or glucose POCT may identify potentially new T2D cases. Identification rates were shown to range between 20-66%.ConclusionWhen a POCT is added as part of a two-staged screening protocol, it enhances the ability to identify more cases correctly and is easily integrated into the dental appointment for chair-side screening. Gingival crevicular blood may be used as an alternative blood source; however, the screening method has limitations. Therefore, the most promising solution seems to be a multi-staged predictive model involving tandem risk questionnaires, periodontal examination, and capillary testing with a chair-side POCT. Background Diabetes has become a growing global public health concern over the years, driven primarily by rising levels of obesity, sedentary lifestyles and an ageing population [1, 2]. Its prevalence has been described as one of the most challenging health problems of the 21st century [1]. Prevalence figures have been progressively increasing, with an estimated 537 million adults said to be living with the disease. The International Diabetes Federation (IDF) reported that 4.2 million adults aged 20–79 were estimated to have died due to diabetes and its complications in 2019 [3] and 6.7 million in 2021 [2]. Recent projections suggest that more than 1.31 billion people could be living with the disease by 2050 worldwide, with the global rise driven predominantly by increasing rates of T2D [4]. Among the various forms of diabetes, Type 2 (T2D) is by far the most common, accounting for approximately 90% of cases in the UK with the current cost of managing it is said to have reached 10% of the annual health budget [5]. Estimates suggest that 921,100 are unaware that they have T2D [2]. Diabetes is often asymptomatic in its initial stages, non-diabetic hyperglycaemia (NDH) and can remain undiagnosed for many years. Evidence suggests that without intervention, a number of patients will develop diabetes within five years [6]. Those affected are more susceptible to diabetes-related complications, particularly those with metabolic syndrome [7], which in turn negatively impacts the future burden on healthcare services [8]. Prevention is critical to interrupt the progression of NDH to T2D and its early complications, including periodontitis to reduce the long-term burden on healthcare services. The inter-relationship between periodontitis and diabetes has been long established [7, 9–12], with a greater understanding that prevention and treatment require the involvement of both medical and oral healthcare providers. Recent developments have seen the medical profession recognise the need to close the gap between oral and general health [13–17]. This growing emphasis on preventive care, disease management, and closer interprofessional collaboration has strengthened the drive for oral healthcare clinicians to screen for diabetes risk at the chair-side [18, 19]. Dental professionals screen and assist patients daily with oral health, positively impacting their overall health [20–24]. They may also be well-placed to risk-assess patients for NDH/T2D. Evidence from studies of immune-senescence and inflammaging suggest, that hyperglycaemia induces inflammaging and diabetes-related tissue lesions, including the inflammatory bone loss seen in periodontitis [25–28]. Therefore, risk-targeted screening may support careful and close monitoring of patients in our care and offer an opportunity for early identification of those who are asymptomatic or unaware of their risk of developing future disease, potentially enabling timely intervention and stabilisation of both diseases. Preliminary screening protocols generally involve a standalone risk questionnaire, a two-stage model that integrates the questionnaire with a periodontal examination, or a multi-stage protocol that concludes with HbA1c-POCT [29–32]. Early detection of abnormal blood glucose levels currently relies primarily on estimating glucose concentration through capillary blood glucose testing [33]. The mechanistic links between periodontitis and diabetes often results in individuals with periodontitis exhibiting gingival inflammation and increased bleeding on probing, reflecting underlying systemic dysregulation [34, 35]. Given that a recognised method of screening for diabetes is from capillary blood collected via a finger-stick test, there may be scope for collecting blood from the gingival tissues for diabetes testing in the dental setting, therefore, making screening at the chair-side using finger-stick blood (FSB) or gingival crevicular blood (GCB) of great interest and relevance to the review as it is pertinent to use in general practice. Thus, this scoping literature review aims to synthesise the evidence on preliminary screening for T2D using HbA1c or glucometric readings in conjunction with a clinical dental protocol to ascertain the value and potential impact of chair-side POCT if implemented in the primary care dental setting. The literature reviewed had a particular focus on the number of cases identified through a chair-side screening protocol when an HbA1c or glucose POCT was added to the screening protocol and whether blood elicited from the gingival sulcus upon periodontal probing can be used as an alternative source to identify dysglycemia at the chair-side. Methodology The pre-specified search strategy was implemented for publications between 1998 and 2023. An initial search using EBSCOhost was conducted for publications between 1998 and 2018 (including PubMed, CINAHL) and Google Scholar and other electronic databases and webpages between 1998 and 2023. The preliminary Boolean search ranged from 1998 to 2018 and resulted in 74,595 papers when (MeSH) terms “Diabetes AND Screening AND Dental” were used and 21,701 when MeSH terms Diabetes Screening AND Periodontal Disease were used. The MeSH terms such as “Diabetes Screening” AND “Periodontal Disease” OR “Diabetes Screening” AND “Periodontitis” OR “Diabetes Mellitus Screening” AND “Periodontal Disease” OR “Diabetes Mellitus Screening” AND “Periodontitis” were searched, filters were added with limiters set on search dates from 1998 to 2018, English language which further resulted in 3013 papers (Table 1). The titles and abstracts of the returned articles were assessed against pre-specified eligibility criteria to ensure that those selected were best suited for comprehensive analysis. Additional searches included manual /electronic searches of websites and a manual search of journals and literature reference lists. Duplicates were eliminated from the set, and those that were dissimilar in the screening method or which did not meet the eligibility criteria. Returned articles and grey literature were screened and used as supportive material for later discussion. Table 1Search strategySearch StrategySearch TermsFiltersArticles ReturnedArticles IncludedEBSCO Host MEDLINE PubMed,CINAHL, Scopus, Dentistry & Oral Science, Complementary Index, Academic Search UltimateMeSH Terms: Diabetes Screening AND Periodontal Disease OR Diabetes Screening AND Periodontitis OR Diabetes Mellitus Screening AND Periodontal Disease OR Diabetes Mellitus Screening AND PeriodontitisSearch dates from 1998–2018English Language301331Google ScholarDiabetes Screening Tool AND DentalDiabetes Screening AND Periodontitis AND Point-of Care TestSearch dates from 1998–2023English Language2306Manual Search Hand-search Electronic databases WebpagesSearch dates from 2018–2023English Language7928Reference ListsSearch dates from 2018–2023English Language2113 Table 1Search strategySearch StrategySearch TermsFiltersArticles ReturnedArticles IncludedEBSCO Host MEDLINE PubMed,CINAHL, Scopus, Dentistry & Oral Science, Complementary Index, Academic Search UltimateMeSH Terms: Diabetes Screening AND Periodontal Disease OR Diabetes Screening AND Periodontitis OR Diabetes Mellitus Screening AND Periodontal Disease OR Diabetes Mellitus Screening AND PeriodontitisSearch dates from 1998–2018English Language301331Google ScholarDiabetes Screening Tool AND DentalDiabetes Screening AND Periodontitis AND Point-of Care TestSearch dates from 1998–2023English Language2306Manual Search Hand-search Electronic databases WebpagesSearch dates from 2018–2023English Language7928Reference ListsSearch dates from 2018–2023English Language2113 Search strategy EBSCO Host MEDLINE PubMed, CINAHL, Scopus, Dentistry & Oral Science, Complementary Index, Academic Search Ultimate Search dates from 1998–2018 English Language Diabetes Screening Tool AND Dental Diabetes Screening AND Periodontitis AND Point-of Care Test Search dates from 1998–2023 English Language Search dates from 2018–2023 English Language Search dates from 2018–2023 English Language Overall, the search strategy produced a wide range of published articles which were reported according to the “Preferred Reporting Items for Systematic Reviews and Meta-Analyses” (PRISMA) guidelines (Fig. 1). The articles that met inclusion were those which undertook a prior risk assessment for NDH/T2D; used HbA1c or glucose POCT in screening protocol; based in a clinical dental setting; the subjects were adults ≥ 18 years of age; and those written in English. Articles that did not undertake a prior risk assessment; did not use blood sample for POCT, non-dental setting; and of non-English language were excluded from the set. Eligible papers were assessed and analysed using the “Critical Appraisal Skills Programme” (CASP)- critical appraisal tool and further synthesised and consolidated towards this review. Nine studies that primarily focused on identifying at-risk individuals through a capillary blood sample elicited through finger puncture and 12 studies that tested blood from the gingival sulcus are included in this review. Results Twenty-one studies met the eligibility criteria and were included in the review (Fig. 1). The characteristics of the included studies are summarised in Table 2. The results are presented in the synthesis tables (Tables 3 and 4), organised thematically. Fig. 1Prisma flow diagram of the search results Prisma flow diagram of the search results Table 2Characteristics of the included studiesRef No.Author & YearSample SizeRisk/Med Hx ScreeningPeriodontal ExaminationBlood Source TestedGlucose TestFSBGCBVBHba1cRBGFBGPP[29]Lalla et al. 2011n=601✓✓✓*✓✓*✓[30]Lalla et al. 2013n = 663✓✓✓*✓✓*✓[36]Genco et al. 2014n = 1022✓✓✓*✓*[37]Franck et al. 2014n = 104✓-✓*✓✓*[38]Herman et al. 2015n = 1033✓✓✓*✓✓*✓[39]Bossart et al. 2016n = 50✓✓✓*✓*[40]Maples et al. 2016n = 500✓-✓*✓*[41]Giblin et al. 2016n = 179✓-✓*✓*[42]Teeuw et al. 2017n = 313✓✓✓*✓✓*[43]Beikler et al.2002n = 45✓✓✓✓*✓*[44]Khader et al. 2006n = 60✓✓✓✓*✓*[45]Sarlati et al. 2010n = 130✓✓✓✓*✓✓*✓[46]Shetty et al. 2013n = 100✓✓✓✓*✓*[20]Strauss et al. 2012n = 120✓✓✓✓*✓*[47]Bhavsar et al.2016n = 70✓✓✓*✓✓*[48]Koneru & Tanikonda 2016n = 454✓✓✓*✓✓*✓[49]Shylaja et al. 2016n = 30✓✓✓✓*✓*✓[50]Singh et al. 2017n = 60✓✓✓✓*✓*[51]Sibyl et al. 2017n = 30✓✓✓✓*✓✓*✓✓[52]Wu et al. 2020n = 60✓✓✓✓*✓✓*[33]Rapone et al. 2020n = 140✓✓✓✓*✓*Abbreviation Key: Ref No Reference number; Med Hx Medical history, FSB Finger-stick blood, GCB Gingival crevicular blood, VB Venous blood, Hba1c Glycated haemoglobin, RBG Random blood glucose, FBG Fasting blood glucose, PP Post-prandial* Used for screening Table 2Characteristics of the included studiesRef No.Author & YearSample SizeRisk/Med Hx ScreeningPeriodontal ExaminationBlood Source TestedGlucose TestFSBGCBVBHba1cRBGFBGPP[29]Lalla et al. 2011n=601✓✓✓*✓✓*✓[30]Lalla et al. 2013n = 663✓✓✓*✓✓*✓[36]Genco et al. 2014n = 1022✓✓✓*✓*[37]Franck et al. 2014n = 104✓-✓*✓✓*[38]Herman et al. 2015n = 1033✓✓✓*✓✓*✓[39]Bossart et al. 2016n = 50✓✓✓*✓*[40]Maples et al. 2016n = 500✓-✓*✓*[41]Giblin et al. 2016n = 179✓-✓*✓*[42]Teeuw et al. 2017n = 313✓✓✓*✓✓*[43]Beikler et al.2002n = 45✓✓✓✓*✓*[44]Khader et al. 2006n = 60✓✓✓✓*✓*[45]Sarlati et al. 2010n = 130✓✓✓✓*✓✓*✓[46]Shetty et al. 2013n = 100✓✓✓✓*✓*[20]Strauss et al. 2012n = 120✓✓✓✓*✓*[47]Bhavsar et al.2016n = 70✓✓✓*✓✓*[48]Koneru & Tanikonda 2016n = 454✓✓✓*✓✓*✓[49]Shylaja et al. 2016n = 30✓✓✓✓*✓*✓[50]Singh et al. 2017n = 60✓✓✓✓*✓*[51]Sibyl et al. 2017n = 30✓✓✓✓*✓✓*✓✓[52]Wu et al. 2020n = 60✓✓✓✓*✓✓*[33]Rapone et al. 2020n = 140✓✓✓✓*✓*Abbreviation Key: Ref No Reference number; Med Hx Medical history, FSB Finger-stick blood, GCB Gingival crevicular blood, VB Venous blood, Hba1c Glycated haemoglobin, RBG Random blood glucose, FBG Fasting blood glucose, PP Post-prandial* Used for screening Characteristics of the included studies Abbreviation Key: Ref No Reference number; Med Hx Medical history, FSB Finger-stick blood, GCB Gingival crevicular blood, VB Venous blood, Hba1c Glycated haemoglobin, RBG Random blood glucose, FBG Fasting blood glucose, PP Post-prandial * Used for screening Table 3Table of synthesis-finger-stick blood (FSB) screening methodAuthor, Year, CountryRef.Study DesignScreening MethodResultsKey FindingsLalla et al. 2011 USA[29]Cohort ProspectiveSample n = 601Purposive SampleAged ≥30 yearsDental Hospital1year durationRisk questionnaire (NHANES) and periodontal examination followed by an HbA1c finger-stick test. Followed by a 2nd visit with an overnight fast- plasma glucose venipuncture test.506 Subjects screened.Prediabetic 161(31.8%)Diabetic 21(4.2%) Results correlated to laboratory test. (AUC=0.79;95%CI, 0.743,0.830; P<0.01)Identification rate through screening: 35.9% Demonstrated that dental care professionals have the potential to identify unrecognised diabetes and prediabetes in dental patients and refer those identified to their GP for further evaluation and care.Lalla et al. 2013 USA(Combined with Lalla et al. 2011)[30]Cross-sectionalSample n=663Purposive SampleAged ≥30 yearsCombined sample n=1097Dental Hospital2 year durationRisk questionnaire (NHANES) and periodontal examination followed by an HbA1c finger-stick test and a venipuncture test at the end of the same visit. 591 Subjects Screened.Prediabetic 275 (46.5%)Diabetic 51 (8.6%)Combined cohort:Prediabetic 436 (39.7%)Diabetic 72(6.6%)Results correlated to laboratory test.(AUC= 0.92; 95% CI: 0.904, 0.944;P<0.001)Identification rate through screening: 55.1% Demonstrated the validity of the screening/prediction model set out irrespective of the type of HbA1c test conducted in identifying prediabetes or diabetes.Identification rate through screening: 46.3%Validated that dental professionals can screen and identify their patients who present with diabetes risk factors with hyperglycaemia and direct them to their GPs for appropriate diagnosis and care.Genco et al. 2014 USA[36]Field TrialSample n=1022Convenience SampleAged ≥45 yearsGeneral/ private specialist practices & community health center.1 year durationRisk questionnaire (ADA-risk test) and periodontal examination followed by an HbA1c finger-stick test.1022 Subjects screened.Prediabetic 34 (23%) Diabetic 18 (12%)Results correlated to laboratory test. (AUC=0.704; p<0.02)Identification rate through screening: 40.7% Demonstrated that screening for prediabetes and diabetes is feasible in dental practice settings, and the model used can help encourage an inter-professional/multi-disciplinary approach to helping patients.Franck et al. 2014 USA[37]Correlational StudySample n=104Convenience SampleAged ≥44 yearsDental HygieneSchool/DentalHospital & Private PracticeDuration n/aRisk questionnaire (HEIKES) and blood pressure measurement, followed by an HbA1c finger-stick test with some sent for an additional VB sample test for laboratory analysis.75 Subjects screened.Hyperglycaemic 34 (45%) Results correlated to laboratory test. (p=0.004; p<0.001)Identification rate through screening: 45.3% Demonstrated that HbA1c screening conducted chairside can easily be adopted in the dental setting and can unveil previously unidentified prediabetic and diabetic in dental patients.Herman et al. 2015 USA[38]Cross-sectional StudySample n= 1033Consecutive SampleAged ≥30yearsGeneral Dental Practices18-month durationRisk questionnaire (established diabetes risk factors) and periodontal examination followed by a random capillary finger-stick test and some sent for additional for VB test for laboratory analysis.181 Subjects screened.Prediabetic 57 (32%)Diabetic 3 (1.7%)Results correlated to confirmatory test. (AUC=0.83;95%CI:0.83-0.79; p<0.0001)Identification rate through screening: 33.1%Demonstrated the potential for the use of simple chair-side screening for dysglycemia to identify high-risk patients and onward referral for definitive diagnostic testing.Bossart et al. 2016 USA[39]Pilot StudySample n=50Purposive SampleAged ≥18 yearsUniversity Dental HospitalDuration n/aRisk questionnaire (ADA-risk test), periodontal examination, and blood pressure measurement, followed by an HbA1c finger-stick test.50 Subjects screened.Prediabetic 16 (32%)Diabetic 1 (2%)Results correlated to confirmatory test-Not reported.Identification rate through screening: 34%Demonstrated that chair-side HbA1c screening was an effective and convenient method for identifying undiagnosed prediabetes and diabetes, and it provides an opportunity for interprofessional patient care.Maples et al. 2016 USA[40]Cross-sectional studySample n=500Convenience SampleAged ≥18 yearsDental Hospital14-month durationRisk questionnaire (based on 13 different screening tools) followed by an HbA1c-finger-stick sample sent for laboratory testing.500 Subjects screened.Prediabetic 96 (19.2%)Diabetic 6 (1.2%)Results upon confirmatory test. (AUC=0.72;95%CI:0.66, 0.78; p <0.05)Identification rate through screening: 20.4%Demonstrated a simple screening tool is viable for identifying patients at moderate and high risk for prediabetes and diabetes in the dental practice setting and can be referred to the GP accordingly.Giblin et al. 2016 USA[41]Pilot StudySample n=179Purposive SampleAged ≥18 yearsDental Hospital Dental Hygiene SchoolDuration n/aRisk questionnaire (ADA-risk test) followed by an HbA1c finger-stick test.41 Subjects screened.Prediabetic 25 (60.8%)Diabetic 2 (4.8%)Results upon confirmatory test. (95% CI:5.70-5.96%)Identification rate through screening: 65.6% Demonstrated that when an HbA1c test is added to the screening protocol, a greater number of cases can be identified; screening in the dental setting provides an opportunity to discuss and identify those at risk of diabetes and refer to their GP accordingly.Teeuw et al. 2017 Netherlands[42]Case-ControlSample n=313Consecutive SampleAged ≥18 yearsExisting dental patientsUniversity Dental Clinic18-month duration Risk questionnaire (based on diabetes-related characteristics) and Periodontal examination, followed by an HbA1c-finger-stick sample collection on Whatman paper-dry-spot sample for laboratory testing.HbA1c Venous sample for Laboratory test313 Subjects screened.Periodontally Healthy:Prediabetic 40 (36.7%)Diabetic 11 (10.1%)Mild/Moderate Periodontitis Group:Prediabetic 58 (46%)Diabetic 17 (14%)Severe Periodontitis Group:Prediabetic 37(47%)Diabetic 18 (23%)Results upon confirmatory test.(P=0.003)Identification rate through screening: 57.8 %Demonstrated the severity of periodontitis being an early sign and a useful indicator for undiagnosed diabetes, with the dental surgery being a suitable location for screening for prediabetes and diabetes to help prevent more severe symptoms and beneficial in the treatment of periodontitis.*An overrepresentation of cases in the periodontitis group was demonstrated due to the parameters used. Table 3Table of synthesis-finger-stick blood (FSB) screening methodAuthor, Year, CountryRef.Study DesignScreening MethodResultsKey FindingsLalla et al. 2011 USA[29]Cohort ProspectiveSample n = 601Purposive SampleAged ≥30 yearsDental Hospital1year durationRisk questionnaire (NHANES) and periodontal examination followed by an HbA1c finger-stick test. Followed by a 2nd visit with an overnight fast- plasma glucose venipuncture test.506 Subjects screened.Prediabetic 161(31.8%)Diabetic 21(4.2%) Results correlated to laboratory test. (AUC=0.79;95%CI, 0.743,0.830; P<0.01)Identification rate through screening: 35.9% Demonstrated that dental care professionals have the potential to identify unrecognised diabetes and prediabetes in dental patients and refer those identified to their GP for further evaluation and care.Lalla et al. 2013 USA(Combined with Lalla et al. 2011)[30]Cross-sectionalSample n=663Purposive SampleAged ≥30 yearsCombined sample n=1097Dental Hospital2 year durationRisk questionnaire (NHANES) and periodontal examination followed by an HbA1c finger-stick test and a venipuncture test at the end of the same visit. 591 Subjects Screened.Prediabetic 275 (46.5%)Diabetic 51 (8.6%)Combined cohort:Prediabetic 436 (39.7%)Diabetic 72(6.6%)Results correlated to laboratory test.(AUC= 0.92; 95% CI: 0.904, 0.944;P<0.001)Identification rate through screening: 55.1% Demonstrated the validity of the screening/prediction model set out irrespective of the type of HbA1c test conducted in identifying prediabetes or diabetes.Identification rate through screening: 46.3%Validated that dental professionals can screen and identify their patients who present with diabetes risk factors with hyperglycaemia and direct them to their GPs for appropriate diagnosis and care.Genco et al. 2014 USA[36]Field TrialSample n=1022Convenience SampleAged ≥45 yearsGeneral/ private specialist practices & community health center.1 year durationRisk questionnaire (ADA-risk test) and periodontal examination followed by an HbA1c finger-stick test.1022 Subjects screened.Prediabetic 34 (23%) Diabetic 18 (12%)Results correlated to laboratory test. (AUC=0.704; p<0.02)Identification rate through screening: 40.7% Demonstrated that screening for prediabetes and diabetes is feasible in dental practice settings, and the model used can help encourage an inter-professional/multi-disciplinary approach to helping patients.Franck et al. 2014 USA[37]Correlational StudySample n=104Convenience SampleAged ≥44 yearsDental HygieneSchool/DentalHospital & Private PracticeDuration n/aRisk questionnaire (HEIKES) and blood pressure measurement, followed by an HbA1c finger-stick test with some sent for an additional VB sample test for laboratory analysis.75 Subjects screened.Hyperglycaemic 34 (45%) Results correlated to laboratory test. (p=0.004; p<0.001)Identification rate through screening: 45.3% Demonstrated that HbA1c screening conducted chairside can easily be adopted in the dental setting and can unveil previously unidentified prediabetic and diabetic in dental patients.Herman et al. 2015 USA[38]Cross-sectional StudySample n= 1033Consecutive SampleAged ≥30yearsGeneral Dental Practices18-month durationRisk questionnaire (established diabetes risk factors) and periodontal examination followed by a random capillary finger-stick test and some sent for additional for VB test for laboratory analysis.181 Subjects screened.Prediabetic 57 (32%)Diabetic 3 (1.7%)Results correlated to confirmatory test. (AUC=0.83;95%CI:0.83-0.79; p<0.0001)Identification rate through screening: 33.1%Demonstrated the potential for the use of simple chair-side screening for dysglycemia to identify high-risk patients and onward referral for definitive diagnostic testing.Bossart et al. 2016 USA[39]Pilot StudySample n=50Purposive SampleAged ≥18 yearsUniversity Dental HospitalDuration n/aRisk questionnaire (ADA-risk test), periodontal examination, and blood pressure measurement, followed by an HbA1c finger-stick test.50 Subjects screened.Prediabetic 16 (32%)Diabetic 1 (2%)Results correlated to confirmatory test-Not reported.Identification rate through screening: 34%Demonstrated that chair-side HbA1c screening was an effective and convenient method for identifying undiagnosed prediabetes and diabetes, and it provides an opportunity for interprofessional patient care.Maples et al. 2016 USA[40]Cross-sectional studySample n=500Convenience SampleAged ≥18 yearsDental Hospital14-month durationRisk questionnaire (based on 13 different screening tools) followed by an HbA1c-finger-stick sample sent for laboratory testing.500 Subjects screened.Prediabetic 96 (19.2%)Diabetic 6 (1.2%)Results upon confirmatory test. (AUC=0.72;95%CI:0.66, 0.78; p <0.05)Identification rate through screening: 20.4%Demonstrated a simple screening tool is viable for identifying patients at moderate and high risk for prediabetes and diabetes in the dental practice setting and can be referred to the GP accordingly.Giblin et al. 2016 USA[41]Pilot StudySample n=179Purposive SampleAged ≥18 yearsDental Hospital Dental Hygiene SchoolDuration n/aRisk questionnaire (ADA-risk test) followed by an HbA1c finger-stick test.41 Subjects screened.Prediabetic 25 (60.8%)Diabetic 2 (4.8%)Results upon confirmatory test. (95% CI:5.70-5.96%)Identification rate through screening: 65.6% Demonstrated that when an HbA1c test is added to the screening protocol, a greater number of cases can be identified; screening in the dental setting provides an opportunity to discuss and identify those at risk of diabetes and refer to their GP accordingly.Teeuw et al. 2017 Netherlands[42]Case-ControlSample n=313Consecutive SampleAged ≥18 yearsExisting dental patientsUniversity Dental Clinic18-month duration Risk questionnaire (based on diabetes-related characteristics) and Periodontal examination, followed by an HbA1c-finger-stick sample collection on Whatman paper-dry-spot sample for laboratory testing.HbA1c Venous sample for Laboratory test313 Subjects screened.Periodontally Healthy:Prediabetic 40 (36.7%)Diabetic 11 (10.1%)Mild/Moderate Periodontitis Group:Prediabetic 58 (46%)Diabetic 17 (14%)Severe Periodontitis Group:Prediabetic 37(47%)Diabetic 18 (23%)Results upon confirmatory test.(P=0.003)Identification rate through screening: 57.8 %Demonstrated the severity of periodontitis being an early sign and a useful indicator for undiagnosed diabetes, with the dental surgery being a suitable location for screening for prediabetes and diabetes to help prevent more severe symptoms and beneficial in the treatment of periodontitis.*An overrepresentation of cases in the periodontitis group was demonstrated due to the parameters used. Table of synthesis-finger-stick blood (FSB) screening method Cohort Prospective Sample n = 601 Purposive Sample Aged ≥30 years Dental Hospital 1year duration Risk questionnaire (NHANES) and periodontal examination followed by an HbA1c finger-stick test. Followed by a 2nd visit with an overnight fast- plasma glucose venipuncture test. 506 Subjects screened. Prediabetic 161(31.8%) Diabetic 21(4.2%) Results correlated to laboratory test. (AUC=0.79;95%CI, 0.743,0.830; P<0.01) Identification rate through screening: 35.9% Demonstrated that dental care professionals have the potential to identify unrecognised diabetes and prediabetes in dental patients and refer those identified to their GP for further evaluation and care. Lalla et al. 2013 USA (Combined with Lalla et al. 2011) Cross-sectional Sample n=663 Purposive Sample Aged ≥30 years Combined sample n=1097 Dental Hospital 2 year duration Risk questionnaire (NHANES) and periodontal examination followed by an HbA1c finger-stick test and a venipuncture test at the end of the same visit. 591 Subjects Screened. Prediabetic 275 (46.5%) Diabetic 51 (8.6%) Combined cohort: Prediabetic 436 (39.7%) Diabetic 72(6.6%) Results correlated to laboratory test. (AUC= 0.92; 95% CI: 0.904, 0.944;P<0.001) Identification rate through screening: 55.1% Demonstrated the validity of the screening/prediction model set out irrespective of the type of HbA1c test conducted in identifying prediabetes or diabetes. Identification rate through screening: 46.3% Validated that dental professionals can screen and identify their patients who present with diabetes risk factors with hyperglycaemia and direct them to their GPs for appropriate diagnosis and care. Field Trial Sample n=1022 Convenience Sample Aged ≥45 years General/ private specialist practices & community health center. 1 year duration Risk questionnaire (ADA-risk test) and periodontal examination followed by an HbA1c finger-stick test. 1022 Subjects screened. Prediabetic 34 (23%) Diabetic 18 (12%) Results correlated to laboratory test. (AUC=0.704; p<0.02) Identification rate through screening: 40.7% Demonstrated that screening for prediabetes and diabetes is feasible in dental practice settings, and the model used can help encourage an inter-professional/multi-disciplinary approach to helping patients. Correlational Study Sample n=104 Convenience Sample Aged ≥44 years Dental Hygiene School/Dental Hospital & Private Practice Duration n/a Risk questionnaire (HEIKES) and blood pressure measurement, followed by an HbA1c finger-stick test with some sent for an additional VB sample test for laboratory analysis. 75 Subjects screened. Hyperglycaemic 34 (45%) Results correlated to laboratory test. (p=0.004; p<0.001) Identification rate through screening: 45.3% Demonstrated that HbA1c screening conducted chairside can easily be adopted in the dental setting and can unveil previously unidentified prediabetic and diabetic in dental patients. Cross-sectional Study Sample n= 1033 Consecutive Sample Aged ≥30years General Dental Practices 18-month duration Risk questionnaire (established diabetes risk factors) and periodontal examination followed by a random capillary finger-stick test and some sent for additional for VB test for laboratory analysis. 181 Subjects screened. Prediabetic 57 (32%) Diabetic 3 (1.7%) Results correlated to confirmatory test. (AUC=0.83;95%CI:0.83-0.79; p<0.0001) Identification rate through screening: 33.1% Demonstrated the potential for the use of simple chair-side screening for dysglycemia to identify high-risk patients and onward referral for definitive diagnostic testing. Pilot Study Sample n=50 Purposive Sample Aged ≥18 years University Dental Hospital Duration n/a Risk questionnaire (ADA-risk test), periodontal examination, and blood pressure measurement, followed by an HbA1c finger-stick test. 50 Subjects screened. Prediabetic 16 (32%) Diabetic 1 (2%) Results correlated to confirmatory test-Not reported. Identification rate through screening: 34% Demonstrated that chair-side HbA1c screening was an effective and convenient method for identifying undiagnosed prediabetes and diabetes, and it provides an opportunity for interprofessional patient care. Cross-sectional study Sample n=500 Convenience Sample Aged ≥18 years Dental Hospital 14-month duration Risk questionnaire (based on 13 different screening tools) followed by an HbA1c-finger-stick sample sent for laboratory testing. 500 Subjects screened. Prediabetic 96 (19.2%) Diabetic 6 (1.2%) Results upon confirmatory test. (AUC=0.72;95%CI:0.66, 0.78; p <0.05) Identification rate through screening: 20.4% Demonstrated a simple screening tool is viable for identifying patients at moderate and high risk for prediabetes and diabetes in the dental practice setting and can be referred to the GP accordingly. Pilot Study Sample n=179 Purposive Sample Aged ≥18 years Dental Hospital Dental Hygiene School Duration n/a Risk questionnaire (ADA-risk test) followed by an HbA1c finger-stick test. 41 Subjects screened. Prediabetic 25 (60.8%) Diabetic 2 (4.8%) Results upon confirmatory test. (95% CI:5.70-5.96%) Identification rate through screening: 65.6% Demonstrated that when an HbA1c test is added to the screening protocol, a greater number of cases can be identified; screening in the dental setting provides an opportunity to discuss and identify those at risk of diabetes and refer to their GP accordingly. Case-Control Sample n=313 Consecutive Sample Aged ≥18 years Existing dental patients University Dental Clinic 18-month duration Risk questionnaire (based on diabetes-related characteristics) and Periodontal examination, followed by an HbA1c-finger-stick sample collection on Whatman paper-dry-spot sample for laboratory testing. HbA1c Venous sample for Laboratory test 313 Subjects screened. Periodontally Healthy: Prediabetic 40 (36.7%) Diabetic 11 (10.1%) Mild/Moderate Periodontitis Group: Prediabetic 58 (46%) Diabetic 17 (14%) Severe Periodontitis Group: Prediabetic 37(47%) Diabetic 18 (23%) Results upon confirmatory test. (P=0.003) Identification rate through screening: 57.8 % Demonstrated the severity of periodontitis being an early sign and a useful indicator for undiagnosed diabetes, with the dental surgery being a suitable location for screening for prediabetes and diabetes to help prevent more severe symptoms and beneficial in the treatment of periodontitis. *An overrepresentation of cases in the periodontitis group was demonstrated due to the parameters used. Table 4Table of synthesis- gingival crevicular blood (GCB) screening methodAuthor, Year, CountryRef.Study DesignScreening MethodResultsKey FindingsBeikler et al. 2002 Germany[43]Pilot studySample n=45Purposive SampleAged 24-78 years32 Non-Diabetic patients 13 Diabetic patients with moderate to severe periodontitisUniversity Dental ClinicDuration n/aMH screened for inclusion. Periodontal examination, and collection of GCB sample followed by FSB sample collected and placed on test strip of monitor.GCB and FSB ranged between3.57mmol/l to 18.01mmol/ml.Very high intra-patient correlation between GCB and FSB readings (r=0.98; p<0.0001); with no significant differences between GCB and FSB sample values (p<0.05).Demonstrated that blood oozing during routine diagnostic periodontal examination can be an excellent source for glucometric analysis.Khader et al. 2006 Jordan[44]Pilot studySample n=60Consecutive SampleAged 33-58 years 26 Non-Diabetic patients 34 Diabetic patients University Dental Clinic3-month durationMH screened for inclusion. Periodontal examination, and collection of GCB and FSB samples following overnight fast.GCB: 125.4±60.7 mg/dLFSB: 131.9±61.1 mg/dLAn almost positive perfect correlation between GCB and FSB sample readings (r=0.997, p<0.0001). However, paired t-test showed a significant difference between GCB and FSB readings mean difference of (7.03mg/100ml P<0.0001).GCB can be an acceptable source for measuring blood glucose levels and leads to the same diagnostic conclusion as blood taken from a finger puncture sample. However, the technique to obtain samples from gingival crevice is not always feasible.Sarlati et al. 2010 Iran[45]Pilot studySample n=130Stratified Random Sample Aged 35-65 years30 Periodontitis patients50 Diabetic patients50 Non-Diabetic patientsUniversity Dental ClinicDuration n/aMH screened for inclusion. Periodontal examination, and collection of GCB and FSB samples. Followed by some undergoing collection of GCB, FSB and an additional fasting VB sample (chair-side) for laboratory analysis (VB).GCB-FSB: 14.26 ±28.45 mg/dL(diabetic group)GCB-FSB: 41.24 ±16.91 mg/dL(non-diabetic group)Significant correlation was shown between GCB and FSB measurements across both groups (r=0.91, p<0.001) 95%CI.Demonstrated that gingival crevicular blood can be used for testing blood glucose during periodontal examination in diabetic patients but not in non-diabetic individuals.Shetty et al. 2013 India[46]Pilot studySample n=100Stratified Random SampleAged 26-66 years50 Diabetic patients50 Non-Diabetic patients With moderate to severe gingivitis with min 1 tooth in maxillary region showing bleeding upon probing.Dental College HospitalDuration n/aMH screened for inclusion. Periodontal examination, and collection of GCB with a glass capillary tube, transferred to the test-strip, followed by FSB sample collection.GCB:193.52 ± 74.93 mg/dL>FSB:218 ±84.04 mg/dL(diabetic group) GCB:97.2 ±15.7 mg/dLFSB:108.4 ±13.84 mg/dL(non-diabetic group)Significant positive correlation was shown between GCB and FSB measurements (r=0.943) diabetic group (r=0.926) non-diabetic groupNo significant difference between GCB and FSB values.(p=0.129) diabetic group(p=0.503) non-diabetic groupGCB collected during periodontal examination may be an excellent source for blood glucometric analysis.Strauss et al. 2012 USA[20]Pilot study Sample n=120Purposive SampleAged ≥18yearsPeriodontitis patients under treatment or maintenance therapy with or without diabetes.University Dental Clinic 3-month durationMH screened for inclusion. Periodontal Examination followed by GCB sample and FSB sample absorbed onto blood collection and card sent for HbA1c laboratory analysis.GCB: not reported.FSB: 6.0%±0.83% GCB and FSB values showed high correlation (r=0.842) and high sensitivity (0.993) and specificity (0.900) when using criterion value of 6.3%(95%CI).Demonstrated that gingival crevicular blood samples are an acceptable method for HbA1c testing to screen for diabetes.Bhavsar et al. 2016 India[47]Pilot studySample n=70Stratified Random Sample Aged 20-70 years35 Non-Diabetic patients35 Diabetic patients with moderate gingivitis and periodontitis. Dental Collage HospitalDuration n/a MH screened for inclusion. Periodontal examination, and collection of GCB sample, followed by collection of VB sample (chair-side) at the same time for estimation.GCB: 156.07±49.23mg/dLVB:156 ±49.89mg/dL(diabetic group) GCB: 90.8±11.07mg/dLVB: 93.41±9.3mg/dL(non-diabetic group)Highly significant correlation was demonstrated between GCB and VB samples for diabetic (r=0.972) and non-diabetic (r=0.721)No significant difference was found between the two samplemethods(P>0.005)Data showed that gingival crevicular blood collected during diagnostic periodontal examination can be an excellent source for estimation of blood sugar or glucometric analysis.The technique demonstrated as a suitable method for routine screening of diabetics and early diagnosis of unknown diabetic cases.Koneru & Tanikonda 2016 India[48]Cross-sectional studySample n=454Stratified Random SampleAged 30-50 yearsUnknown diabetes with minimum 1 positive bleeding on probing site.University Dental ClinicDuration n/aMH screened for inclusion. Periodontal examination, collection of GCB sample. Followed by a 2nd visit for fasting VB sample collection for laboratory analysis.GCB:64 in diabetes range.390 not diabetic.VB: 24 in diabetes range.36 in prediabetes range.382 not diabetic. Comparison of GCB and VB showed sensitivity of 96.66% and specificity of 99.47%.The results demonstrated blood obtained from periodontal pocket probing is a reliable sample to screen diabetes in periodontal disease populations.Shylaja et al. 2016 India[49]Pilot studySample n=30Purposive SampleAged 30-60 yearsPatients with moderate periodontitis with positive bleeding on probing; with and without diabetes.Dental College HospitalDuration n/a MH screened for inclusion. Periodontal examination, and collection of fasting GCB collection with a glass capillary tube, transferred to the test-strip, followed by FSB sample collection. Followed by confirmatory VB post-prandial test upon 75mg glucose consumption.GCB: 110 ±14mg/dLFSB: 109 ±18mg/dL(fasting)GCB: 163 ± 18mg/dLFSB: 158 ±20mg/dL(post-prandial)GCB and FSB did not differ either during fasting or post prandial (p>0.05)Demonstrated gingival crevicular blood from probing can be a good source of blood for estimating blood glucose levels and screening for diabetes using portable glucose monitors; as a simple and relatively inexpensive dental practice screening procedure for any patient suspected to have diabetes.Singh et al. 2017 India[50]Pilot studySample n=60Convenience SampleAged 42-55 yearsPatients with gingivitis and with periodontitis and those with ≥1 positive bleeding on probing site.University Dental Clinic from outreach programs5-day durationMH screened for inclusion. Periodontal examination, followed by collection of GCB and FSB samples.GCB: 137.15±18.36 mg/dLFSB: 134.24±16.45mg/dlStrong correlation was shown between GCB and FSB samples (r=0.94; p<0.0001).The data demonstrated that gingival crevicular blood collected diagnostic periodontal examination could be an excellent source for glucometric analysis.Sibyl et al. 2017 India[51]Pilot StudySample n=30Purposive SampleAged 35>Patients with moderate-severe periodontitis with undiagnosed diabetes. Dental College Hospital1-week durationMH screened for inclusion. Periodontal examination, followed by collection of GCB and FSB samples. Later followed by VB for fasting and post-prandial test upon 75mg glucose consumption.GCB: not reported.FSB: not reported.A strong correlation was found between GCB and FSB values (r=0.97, P<0.01).Blood oozing during periodontal examination can be used for diabetes screening.Wu et al. 2020 China[52]Pilot StudySample n=60Purposive SampleAged 20-70 years42 Non-Diabetic patients 18 Diabetic patients with moderate to severe periodontitis.University Dental Clinic18-month durationMH screened for inclusion. Periodontal examination followed by collection of GCB and FSB samples. GCB and FSB sample were collected in EDTA-treated tubes and used for HbA1c analysis.GCB: 7.96±3.56 mmol/LFSB: 8.09 ±3.81 mmol/LGCB:6.03±1.58% HbA1cFSB: 6.01±1.48% HbA1cHighly significant correlations found between GCB and FSB values.Diabetic group (r=0.993)Non-diabetic group (r=0.977)Highly significant correlations found between GCB and FSB groups for HbA1c Diabetic group (r=0.977)Non-Diabetic group (r=0.829)GCB can be used to estimate blood glucose and Hba1c levels.Rapone et al.2020 Italy[33]Cross-sectional StudySample n=140Purposive SampleAged 31-67 years70 Diabetic patients70 Non-Diabetic patients with positive bleeding on probing.University Dental ClinicDuration n/aMH screened for inclusion. Periodontal examination, and collection of GCB and FSB samples with a glass capillary tube and transferred to the test-strip.GCB: 160.42 ±31.31mg/dLFSB: 161.64 ± 31.56mg/dL(diabetic group)GCB: 93.93 ± 20.93mg/dLFSB: 90.88 ± 19.38mg/dL(non-diabetic group) The difference between GCB and FSB groups was non-significant (p<0.05) in diabetic and non-diabetic patients.Highly significant correlation between FSB and GCB for the diabetic group (r=0.9834) and non-diabetic group (r=0.8153).GCB blood test was demonstrated to be a feasible and useful screening tool test for detecting diabetes and could be useful to monitor diabetes. Table 4Table of synthesis- gingival crevicular blood (GCB) screening methodAuthor, Year, CountryRef.Study DesignScreening MethodResultsKey FindingsBeikler et al. 2002 Germany[43]Pilot studySample n=45Purposive SampleAged 24-78 years32 Non-Diabetic patients 13 Diabetic patients with moderate to severe periodontitisUniversity Dental ClinicDuration n/aMH screened for inclusion. Periodontal examination, and collection of GCB sample followed by FSB sample collected and placed on test strip of monitor.GCB and FSB ranged between3.57mmol/l to 18.01mmol/ml.Very high intra-patient correlation between GCB and FSB readings (r=0.98; p<0.0001); with no significant differences between GCB and FSB sample values (p<0.05).Demonstrated that blood oozing during routine diagnostic periodontal examination can be an excellent source for glucometric analysis.Khader et al. 2006 Jordan[44]Pilot studySample n=60Consecutive SampleAged 33-58 years 26 Non-Diabetic patients 34 Diabetic patients University Dental Clinic3-month durationMH screened for inclusion. Periodontal examination, and collection of GCB and FSB samples following overnight fast.GCB: 125.4±60.7 mg/dLFSB: 131.9±61.1 mg/dLAn almost positive perfect correlation between GCB and FSB sample readings (r=0.997, p<0.0001). However, paired t-test showed a significant difference between GCB and FSB readings mean difference of (7.03mg/100ml P<0.0001).GCB can be an acceptable source for measuring blood glucose levels and leads to the same diagnostic conclusion as blood taken from a finger puncture sample. However, the technique to obtain samples from gingival crevice is not always feasible.Sarlati et al. 2010 Iran[45]Pilot studySample n=130Stratified Random Sample Aged 35-65 years30 Periodontitis patients50 Diabetic patients50 Non-Diabetic patientsUniversity Dental ClinicDuration n/aMH screened for inclusion. Periodontal examination, and collection of GCB and FSB samples. Followed by some undergoing collection of GCB, FSB and an additional fasting VB sample (chair-side) for laboratory analysis (VB).GCB-FSB: 14.26 ±28.45 mg/dL(diabetic group)GCB-FSB: 41.24 ±16.91 mg/dL(non-diabetic group)Significant correlation was shown between GCB and FSB measurements across both groups (r=0.91, p<0.001) 95%CI.Demonstrated that gingival crevicular blood can be used for testing blood glucose during periodontal examination in diabetic patients but not in non-diabetic individuals.Shetty et al. 2013 India[46]Pilot studySample n=100Stratified Random SampleAged 26-66 years50 Diabetic patients50 Non-Diabetic patients With moderate to severe gingivitis with min 1 tooth in maxillary region showing bleeding upon probing.Dental College HospitalDuration n/aMH screened for inclusion. Periodontal examination, and collection of GCB with a glass capillary tube, transferred to the test-strip, followed by FSB sample collection.GCB:193.52 ± 74.93 mg/dL>FSB:218 ±84.04 mg/dL(diabetic group) GCB:97.2 ±15.7 mg/dLFSB:108.4 ±13.84 mg/dL(non-diabetic group)Significant positive correlation was shown between GCB and FSB measurements (r=0.943) diabetic group (r=0.926) non-diabetic groupNo significant difference between GCB and FSB values.(p=0.129) diabetic group(p=0.503) non-diabetic groupGCB collected during periodontal examination may be an excellent source for blood glucometric analysis.Strauss et al. 2012 USA[20]Pilot study Sample n=120Purposive SampleAged ≥18yearsPeriodontitis patients under treatment or maintenance therapy with or without diabetes.University Dental Clinic 3-month durationMH screened for inclusion. Periodontal Examination followed by GCB sample and FSB sample absorbed onto blood collection and card sent for HbA1c laboratory analysis.GCB: not reported.FSB: 6.0%±0.83% GCB and FSB values showed high correlation (r=0.842) and high sensitivity (0.993) and specificity (0.900) when using criterion value of 6.3%(95%CI).Demonstrated that gingival crevicular blood samples are an acceptable method for HbA1c testing to screen for diabetes.Bhavsar et al. 2016 India[47]Pilot studySample n=70Stratified Random Sample Aged 20-70 years35 Non-Diabetic patients35 Diabetic patients with moderate gingivitis and periodontitis. Dental Collage HospitalDuration n/a MH screened for inclusion. Periodontal examination, and collection of GCB sample, followed by collection of VB sample (chair-side) at the same time for estimation.GCB: 156.07±49.23mg/dLVB:156 ±49.89mg/dL(diabetic group) GCB: 90.8±11.07mg/dLVB: 93.41±9.3mg/dL(non-diabetic group)Highly significant correlation was demonstrated between GCB and VB samples for diabetic (r=0.972) and non-diabetic (r=0.721)No significant difference was found between the two samplemethods(P>0.005)Data showed that gingival crevicular blood collected during diagnostic periodontal examination can be an excellent source for estimation of blood sugar or glucometric analysis.The technique demonstrated as a suitable method for routine screening of diabetics and early diagnosis of unknown diabetic cases.Koneru & Tanikonda 2016 India[48]Cross-sectional studySample n=454Stratified Random SampleAged 30-50 yearsUnknown diabetes with minimum 1 positive bleeding on probing site.University Dental ClinicDuration n/aMH screened for inclusion. Periodontal examination, collection of GCB sample. Followed by a 2nd visit for fasting VB sample collection for laboratory analysis.GCB:64 in diabetes range.390 not diabetic.VB: 24 in diabetes range.36 in prediabetes range.382 not diabetic. Comparison of GCB and VB showed sensitivity of 96.66% and specificity of 99.47%.The results demonstrated blood obtained from periodontal pocket probing is a reliable sample to screen diabetes in periodontal disease populations.Shylaja et al. 2016 India[49]Pilot studySample n=30Purposive SampleAged 30-60 yearsPatients with moderate periodontitis with positive bleeding on probing; with and without diabetes.Dental College HospitalDuration n/a MH screened for inclusion. Periodontal examination, and collection of fasting GCB collection with a glass capillary tube, transferred to the test-strip, followed by FSB sample collection. Followed by confirmatory VB post-prandial test upon 75mg glucose consumption.GCB: 110 ±14mg/dLFSB: 109 ±18mg/dL(fasting)GCB: 163 ± 18mg/dLFSB: 158 ±20mg/dL(post-prandial)GCB and FSB did not differ either during fasting or post prandial (p>0.05)Demonstrated gingival crevicular blood from probing can be a good source of blood for estimating blood glucose levels and screening for diabetes using portable glucose monitors; as a simple and relatively inexpensive dental practice screening procedure for any patient suspected to have diabetes.Singh et al. 2017 India[50]Pilot studySample n=60Convenience SampleAged 42-55 yearsPatients with gingivitis and with periodontitis and those with ≥1 positive bleeding on probing site.University Dental Clinic from outreach programs5-day durationMH screened for inclusion. Periodontal examination, followed by collection of GCB and FSB samples.GCB: 137.15±18.36 mg/dLFSB: 134.24±16.45mg/dlStrong correlation was shown between GCB and FSB samples (r=0.94; p<0.0001).The data demonstrated that gingival crevicular blood collected diagnostic periodontal examination could be an excellent source for glucometric analysis.Sibyl et al. 2017 India[51]Pilot StudySample n=30Purposive SampleAged 35>Patients with moderate-severe periodontitis with undiagnosed diabetes. Dental College Hospital1-week durationMH screened for inclusion. Periodontal examination, followed by collection of GCB and FSB samples. Later followed by VB for fasting and post-prandial test upon 75mg glucose consumption.GCB: not reported.FSB: not reported.A strong correlation was found between GCB and FSB values (r=0.97, P<0.01).Blood oozing during periodontal examination can be used for diabetes screening.Wu et al. 2020 China[52]Pilot StudySample n=60Purposive SampleAged 20-70 years42 Non-Diabetic patients 18 Diabetic patients with moderate to severe periodontitis.University Dental Clinic18-month durationMH screened for inclusion. Periodontal examination followed by collection of GCB and FSB samples. GCB and FSB sample were collected in EDTA-treated tubes and used for HbA1c analysis.GCB: 7.96±3.56 mmol/LFSB: 8.09 ±3.81 mmol/LGCB:6.03±1.58% HbA1cFSB: 6.01±1.48% HbA1cHighly significant correlations found between GCB and FSB values.Diabetic group (r=0.993)Non-diabetic group (r=0.977)Highly significant correlations found between GCB and FSB groups for HbA1c Diabetic group (r=0.977)Non-Diabetic group (r=0.829)GCB can be used to estimate blood glucose and Hba1c levels.Rapone et al.2020 Italy[33]Cross-sectional StudySample n=140Purposive SampleAged 31-67 years70 Diabetic patients70 Non-Diabetic patients with positive bleeding on probing.University Dental ClinicDuration n/aMH screened for inclusion. Periodontal examination, and collection of GCB and FSB samples with a glass capillary tube and transferred to the test-strip.GCB: 160.42 ±31.31mg/dLFSB: 161.64 ± 31.56mg/dL(diabetic group)GCB: 93.93 ± 20.93mg/dLFSB: 90.88 ± 19.38mg/dL(non-diabetic group) The difference between GCB and FSB groups was non-significant (p<0.05) in diabetic and non-diabetic patients.Highly significant correlation between FSB and GCB for the diabetic group (r=0.9834) and non-diabetic group (r=0.8153).GCB blood test was demonstrated to be a feasible and useful screening tool test for detecting diabetes and could be useful to monitor diabetes. Table of synthesis- gingival crevicular blood (GCB) screening method Pilot study Sample n=45 Purposive Sample Aged 24-78 years 32 Non-Diabetic patients 13 Diabetic patients with moderate to severe periodontitis University Dental Clinic Duration n/a GCB and FSB ranged between 3.57mmol/l to 18.01mmol/ml. Very high intra-patient correlation between GCB and FSB readings (r=0.98; p<0.0001); with no significant differences between GCB and FSB sample values (p<0.05). Pilot study Sample n=60 Consecutive Sample Aged 33-58 years 26 Non-Diabetic patients 34 Diabetic patients University Dental Clinic 3-month duration GCB: 125.4±60.7 mg/dL FSB: 131.9±61.1 mg/dL An almost positive perfect correlation between GCB and FSB sample readings (r=0.997, p<0.0001). However, paired t-test showed a significant difference between GCB and FSB readings mean difference of (7.03mg/100ml P<0.0001). Pilot study Sample n=130 Stratified Random Sample Aged 35-65 years 30 Periodontitis patients 50 Diabetic patients 50 Non-Diabetic patients University Dental Clinic Duration n/a GCB-FSB: 14.26 ±28.45 mg/dL (diabetic group) GCB-FSB: 41.24 ±16.91 mg/dL (non-diabetic group) Significant correlation was shown between GCB and FSB measurements across both groups (r=0.91, p<0.001) 95%CI. Pilot study Sample n=100 Stratified Random Sample Aged 26-66 years 50 Diabetic patients 50 Non-Diabetic patients With moderate to severe gingivitis with min 1 tooth in maxillary region showing bleeding upon probing. Dental College Hospital Duration n/a GCB:193.52 ± 74.93 mg/dL> FSB:218 ±84.04 mg/dL (diabetic group) GCB:97.2 ±15.7 mg/dL FSB:108.4 ±13.84 mg/dL (non-diabetic group) Significant positive correlation was shown between GCB and FSB measurements (r=0.943) diabetic group (r=0.926) non-diabetic group No significant difference between GCB and FSB values. (p=0.129) diabetic group (p=0.503) non-diabetic group Pilot study Sample n=120 Purposive Sample Aged ≥18years Periodontitis patients under treatment or maintenance therapy with or without diabetes. University Dental Clinic 3-month duration GCB: not reported. FSB: 6.0%±0.83% GCB and FSB values showed high correlation (r=0.842) and high sensitivity (0.993) and specificity (0.900) when using criterion value of 6.3%(95%CI). Pilot study Sample n=70 Stratified Random Sample Aged 20-70 years 35 Non-Diabetic patients 35 Diabetic patients with moderate gingivitis and periodontitis. Dental Collage Hospital Duration n/a GCB: 156.07±49.23mg/dL VB:156 ±49.89mg/dL (diabetic group) GCB: 90.8±11.07mg/dL VB: 93.41±9.3mg/dL (non-diabetic group) Highly significant correlation was demonstrated between GCB and VB samples for diabetic (r=0.972) and non-diabetic (r=0.721) No significant difference was found between the two samplemethods(P>0.005) Data showed that gingival crevicular blood collected during diagnostic periodontal examination can be an excellent source for estimation of blood sugar or glucometric analysis. The technique demonstrated as a suitable method for routine screening of diabetics and early diagnosis of unknown diabetic cases. Cross-sectional study Sample n=454 Stratified Random Sample Aged 30-50 years Unknown diabetes with minimum 1 positive bleeding on probing site. University Dental Clinic Duration n/a GCB:64 in diabetes range. 390 not diabetic. VB: 24 in diabetes range. 36 in prediabetes range. 382 not diabetic. Comparison of GCB and VB showed sensitivity of 96.66% and specificity of 99.47%. Pilot study Sample n=30 Purposive Sample Aged 30-60 years Patients with moderate periodontitis with positive bleeding on probing; with and without diabetes. Dental College Hospital Duration n/a GCB: 110 ±14mg/dL FSB: 109 ±18mg/dL (fasting) GCB: 163 ± 18mg/dL FSB: 158 ±20mg/dL (post-prandial) GCB and FSB did not differ either during fasting or post prandial (p>0.05) Pilot study Sample n=60 Convenience Sample Aged 42-55 years Patients with gingivitis and with periodontitis and those with ≥1 positive bleeding on probing site. University Dental Clinic from outreach programs 5-day duration GCB: 137.15±18.36 mg/dL FSB: 134.24±16.45mg/dl Strong correlation was shown between GCB and FSB samples (r=0.94; p<0.0001). Pilot Study Sample n=30 Purposive Sample Aged 35>Patients with moderate-severe periodontitis with undiagnosed diabetes. Dental College Hospital 1-week duration GCB: not reported. FSB: not reported. A strong correlation was found between GCB and FSB values (r=0.97, P<0.01). Pilot Study Sample n=60 Purposive Sample Aged 20-70 years 42 Non-Diabetic patients 18 Diabetic patients with moderate to severe periodontitis. University Dental Clinic 18-month duration GCB: 7.96±3.56 mmol/L FSB: 8.09 ±3.81 mmol/L GCB:6.03±1.58% HbA1c FSB: 6.01±1.48% HbA1c Highly significant correlations found between GCB and FSB values. Diabetic group (r=0.993) Non-diabetic group (r=0.977) Highly significant correlations found between GCB and FSB groups for HbA1c Diabetic group (r=0.977) Non-Diabetic group (r=0.829) Cross-sectional Study Sample n=140 Purposive Sample Aged 31-67 years 70 Diabetic patients 70 Non-Diabetic patients with positive bleeding on probing. University Dental Clinic Duration n/a GCB: 160.42 ±31.31mg/dL FSB: 161.64 ± 31.56mg/dL (diabetic group) GCB: 93.93 ± 20.93mg/dL FSB: 90.88 ± 19.38mg/dL (non-diabetic group) The difference between GCB and FSB groups was non-significant (p<0.05) in diabetic and non-diabetic patients. Highly significant correlation between FSB and GCB for the diabetic group (r=0.9834) and non-diabetic group (r=0.8153). Nine studies reported FSB testing of which six used a protocol which consisted of a tandem risk questionnaire, periodontal examination and a capillary finger-stick measurement [29, 30, 36, 38, 39, 42]. Three studies used a two-step protocol excluding the periodontal examination, of which one used periodontal disease risk questions in a self-reported risk questionnaire [40] and two excluded periodontal parameters altogether [37, 41]. Across all nine studies, FSB samples were collected chair-side in the dental setting for the POCT-based screening [29, 30, 36–42]. To evaluate sensitivity and specificity, five studies in the FSB group [29, 30, 37, 38, 42] also obtained venous blood (VB) samples for definitive laboratory analysis. All twelve GCB studies used a protocol that consisted of a periodontal examination and a POCT test with GCB and FSB or VB samples [20, 33, 43–52]. Ten of the twelve GCB studies compared GCB to FSB samples [20, 33, 43–46, 49–52] while two compared GCB to VB [47, 48]. In all twelve studies, GCB samples were collected chair-side in the dental setting for the POCT-based screening [20, 33, 43–52]. In addition, two studies, within the GCB group [45, 51] also acquired VB samples for definitive laboratory confirmation. The combined samples recruited amongst the selected studies in the FSB group were 4465 of which 3594 subjects (80.4%) were found to be at potential risk and put forward for testing [29, 30, 36–42] and 1299 subjects in the GCB test group [20, 33, 43–52]. The identification rates across the FSB group ranged between 20.4 and 65.6% of the studies assessing the HbA1c or glucose POCT screening protocol [30, 36–42]. Across the correlation studies (shown in Table 4), statistically significant positive correlations were identified between the comparators of GCB to FSB and GCB to VB. Eight studies reported highly significant correlations when GCB was compared with FSB samples [20, 33, 43, 44, 49–52]. In addition, a highly significant correlation was observed between GCB and VB samples [47]. One study also reported a strong and significant correlation between GCB and FSB [46]. Two of the twelve studies showed a near-perfect correlation [44, 49]. Three studies showed high sensitivity and specificity of the GCB sample measurements obtained by glucometer when a confirmatory laboratory test was conducted [20, 45, 48]. There was no significant difference between the two blood sources when used for chair-side testing to identify potential prediabetes and diabetes cases, irrespective of whether the capillary blood is sourced from the finger or gingival sulcus [33, 43, 46, 49]; anterior cubital vein or gingival sulcus upon analysis [47, 48]. Discussion The reviewed literature was consistent with the six existing systematic reviews [53–58] and, more recently, a large study in a German population which reported significantly positive predictive values when a dentally focused, targeted-risk protocol was used to identify those at risk of NDH or undiagnosed diabetes [59]. Chair-side screening could help healthcare professionals intervene in early case detection of NDH/ T2D, enabling close monitoring and tighter glucose control of the periodontally compromised patient living with NDH/ T2D. Intervention studies have shown that the treatment of periodontitis results in a greater reduction of systemic inflammatory markers and improves glycaemic control of periodontitis patients with diabetes, which may significantly improve health outcomes [60]. Given the close correlation between the two diseases, chair-side screening may offer an opportunity for early detection of individuals at risk and enable timely and appropriate treatment and stabilisation of both diseases. The concept of screening for diabetes in a dental setting using predictive models and a multi-disciplinary approach to care has gained interest in recent years. Various screening methods have been explored over the years for diabetes screening/case detection in dental care settings. Many of these have been too complex, creating challenges relating to implementation and integration into the dental appointment or not being conducive to testing in primary care dental settings, for example, fasting plasma glucose testing [29, 37], saliva testing [61–63] or urine testing [64]. Alternative, and more suitable chair-side tests have been studied further, particularly the HbA1c or glucose POCT. The present literature reviewed searched for a multi-staged predictive model in tandem with a HbA1c or glucose POCT. The predictive model consisted of a risk questionnaire and a periodontal examination to stratify those in greatest need, followed by an HbA1c or glucose POCT for those exceeding the model threshold. This approach seemingly balances risk and cost, with only those at greatest risk (determined by risk questionnaires) receiving the more expensive POCT. It is reported that for diabetes-dental screening, ‘population-based screening’ where all would receive a POCT is time-consuming and uneconomical [65, 66]; therefore, population-based screening is not advocated for dental settings, but rather a two-phased risk-targeted approach is preferred. The literature, however, highlighted the benefits of chair-side screening and demonstrated how a multi-staged risk assessment process integrated with a simple POCT using an HbA1c monitor could enhance the predictability of risk assessments in dental settings [20, 29, 30, 33, 36–52]. Although HbA1c or glucose POCT monitors can be used alone, when added to such a screening protocol, they were shown to enhance the identification of cases [29, 30, 36–42]. Several authors support this, including Barasch et al. [67], Vadakkekuttical et al. [68] and Lalla and colleagues, who found sensitivity of the testing process to increase from 72% to 92% when the HbA1c-POCT was added to the protocol compared to risk questionnaires alone or of protocols combined with a risk questionnaire and a periodontal examination [29, 30]. The literature demonstrated that self-monitoring devices achieved identification rates ranging from 20 to 66% (mean 42%) [29, 30, 36–42]. Similarly, and consistent with this Parker et al. [69] and Friman et al. [70] found identification rates of 40%, which also successfully correlated with definitive medical testing. Overall, the literature demonstrated the HbA1c-glucose monitors as sensitive and reliable tools that provide consistent results that correlate well with laboratory methods [29, 30, 36–38, 42, 43, 46–49, 51, 71]. They are more suitable and easier to integrate into dental appointments than other tests, lending further to their credibility for diabetes-dental screening. Whilst the efficacy has been established, it has been reported that patients can often be psychologically opposed to receiving finger-stick POCT, reporting finger-prick anxiety, general anxiety and stress [33, 72]. Studies suggest patients can be apprehensive about the pain associated with the lancet used for the finger puncture and, therefore, more amenable to less invasive techniques [20, 43, 46, 47, 73]. Consequently, alternative, minimally invasive strategies for sourcing blood for chair-side screening have been explored, notably utilising blood from the gingival crevice. The literature reviewed demonstrated that GCB can be used for testing blood glucose during periodontal examination [33, 45, 46, 51, 52]. The profuse bleeding elicited from the gingival sulcus when undertaking periodontal examination in those with active periodontitis, may provide a ‘good source’ of blood for use in chair-side testing [33, 43–45, 47–52]. Also, GCB is an acceptable [20, 44], reliable source to screen for diabetes in periodontal disease populations [48], described by several authors as an excellent source of blood for glucometric analysis [43, 46, 47, 50]. The technique for GCB collection during diagnostic periodontal examination is described in the literature as a convenient screening tool, with the ability to perform a test at the chair-side that is safe, easy to perform, and comfortable for the patient [51] and more acceptable than alternative invasive methods [43, 46]. Its rapidity and extensive availability provided greater patient acceptance, as the collection was quick and easy, as demonstrated by Rosedale and Strauss [73] and Sande and colleagues [74]. Its simplicity, cheapness, and minimum disturbance for individuals [33, 43, 46] make it a suitable alternative source for HbA1c or glucometric measurement. Nevertheless, this phenomenon has not been without controversy. Previous studies found that although GCB was a convenient source for glucometric testing in the initial phase, it was less suitable for the monitoring phase as tissue improvements seen following periodontal therapy meant adequate blood samples from the gingival sulcus would not be available, potentially impeding the glucometric monitoring, observed by Strauss and colleagues [20]. However, literature has since found that with developments in glucose monitors, second generation monitors are now more sensitive and able to elicit results with much smaller blood quantities [43, 45, 47, 51]. In fact, Yared et al. [75] found that most new glucose monitors achieve glucose level estimation with as little as 1–3 µL GCB, as opposed to 10–15µL of blood volumes, found in studies with first generation monitors [69, 75]. Further, Parker and colleagues suggested laboratory glucose values obtained by measuring venous blood to be closer to capillary blood values taken from the gingival sulcus rather than blood taken from the finger [69]. They explained that as blood travels from the capillary to the venous circulation, the blood glucose values reduce by approximately 3.5 mg/dL due to glycolysis bringing finger blood glucose values down, further validating its efficacy in detecting dysglycemia. Understandably, this method has some limitations, such as the risk of blood sample contamination, as seen in studies by Khader et al. [44] and Strauss et al. [20]. Khader and colleagues reported lower readings in the GCB group, attributing this to the potential contamination of gingival blood samples with plaque and dilution from saliva or gingival crevicular fluid (GCF) [44]. Although an increase in inflammation in the periodontal tissues is often seen in those with dysglycemia, evidence suggests an increase in GCF levels caused by the inflammatory changes are seen to be greater when compared to non-diabetics with the same level of periodontal disease [51]. Hence, contamination of the blood sample by GCF would have been attributed to the sample being diluted with increased levels of GCF at the collection site. Similarly, Strauss et al. [20] reported that contamination occurred when samples contacted oral tissues, debris, saliva, bacteria, or remnants of a pre-procedural mouth rinse. The risk increased when GCB was collected from posterior or mandibular sites due to insufficient bleeding in the routine anterior maxillary area. Such challenges observed with insufficient blood volumes can impede intra-oral blood sample collection at the chair-side, particularly in cases with diabetic patients with good glucose control or those without periodontitis who are unlikely to have sufficient crevicular bleeding. In patients undergoing maintenance therapy, where there has been successful resolution of gingival and periodontal inflammation, blood sources are less likely to exhibit bleeding, similar to those with a positive smoking history. Hence, it was noted by Strauss et al. [20], who included subjects under maintenance therapy, that some participants could not provide adequate bleeding for the GCB sample, with only 1/3rd of the tip on the collection card reported being covered and found by the laboratory to be inadequate for testing . Further limitations include the risk of potential damage to the test strip. Shetty et al. [46] found that rubbing or direct wiping of intra-oral blood from the gingival tissues onto the test strip to cause damage to the strip’s chemical indicator surface. Furthermore, several studies used random blood glucose measurements with glucometers for blood glucose testing [33, 43–52]. Glucometers do not measure HbA1c and, therefore, only provide a measure of blood glucose at a given point in time rather than the 3-month period that HbA1c monitors reflect. However, it is noteworthy that the POCT was intended for screening rather than diagnosis, with those found at true risk being sent for confirmatory testing. Including a POCT may improve the specificity of testing, ensuring those referred to the medical practitioner for definitive diagnostic testing are accurately identified and at true risk [76]. Risk-targeted screening could be a successful and cost-effective method for identifying disease prevalence, provided there is closer interprofessional working and two-way feedback addressing the patient’s metabolic control and periodontal health status [22, 31, 32, 77–79]. Evidence suggests that screening for diabetes by oral healthcare providers can only be effective if those requiring medical evaluation follow-up with diagnostic testing with the medical practitioner [39]. Several studies highlighted a lack of patient-physician follow-up when a confirmatory test was required [29, 30, 36–39, 41]. Nevertheless, the reviewed literature showed the positive impact of early identification of hyperglycaemia in the dental setting through chair-side screening when an HbA1c or glucose POCT is added to a screening protocol. Conclusion The evidence reviewed indicates that while there are some limitations, dysglycemia in periodontally compromised patients can be identified through chair-side HbA1c or glucose screening protocols. The evidence demonstrates the benefits and challenges of chair-side screening. However, the cost saving of screening and early intervention compared to the long-term costs associated with managing diabetes-related complications would seem to outweigh the limitations [5]. Thus, the most promising solution seems to be a multi-staged predictive model involving tandem risk questionnaires, periodontal examination, and capillary testing. Of course, more robust, and larger-scale studies employing large sample sizes, externally validated questionnaires, and subsequent capillary HbA1c or glucose POCT for those identified as being at high-risk are essential if cost-effective care pathways are to be developed in the future. Nevertheless, to date, the literature seems promising.